In vivo description of dendritic cells in human renal cell carcinoma

Journal of Urology

Volumn 162, Issue 2, 1999, Pages 567-573

  Schwaab, Thomas ^b   Schned, Alan R ^b   Heaney, John A ^b   Cole, Bernard F ^b   Atzpodien, Jens ^b   Wittke, Frederick ^b   Ernstoff, Marc S ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE

Author keywords

Antigen presentation; Dendritic cells; Renal cell carcinoma

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MICROSCOPY; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION;

EID: 0032863781     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68628-4     Document Type: Article

References (39)

1. Steinman, R. M.: The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol., 9: 271, 1991.
2. Freudenthal, P. S. and Steinman, R. M.: The distinct surface human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA, 87: 7698, 1990.
3. Hart, D. N. J.: Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 90: 3245, 1997.
4. Hart, D. N. J. and Fabre, J. W.: Demonstration and characterization of Ia positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not the brain. J. Exp. Med., 154: 347, 1981.
5. Fanger, N. A., Wardwell, K., Shen, L., Tedder, T. F. and Guyre, P. M. Type I (CD64) and Type II (CD32) Fey receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol., 157: 541, 1996.
6. Scheicher, C., Mehlig, M., Dienes, H. and Reske, K.: Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in upregulation of interleukin-1α and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur. J. Immunol., 25: 1566, 1995.
7. Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A. M., Fantham, C. G., Inaba, K. and Steinman, R. M.: Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med., 169: 1169, 1989.
8. Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P. and Pearson, T. C.: Regulation of immunostimulatory function and costimulatory molecule (B7.1 and B7.2) expression on murine dendritic cells. J. Immunol., 152: 5208, 1994.
9. Zhou, L. and Tedder, T. F.: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol., 154: 3821, 1995.
10. Zhou, L., Schwarting, R., Smith, H. M. and Tedder, T. F.: A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol., 149: 735, 1992.
11. Tazi, A., Bouchonnet, F., Grandsaigne, M., Boumsell, L., Hance, A. J. and Soler, P.: Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J. Clin. Invest., 91: 566, 1993.
12. Austyn J. M.: The dendritic cell system and anti-tumor immunity. In Vivo, 7: 193, 1993.
13. Buelens, C., Willems, F., Delvaux, A., Pierard, G., Delville, J-P., Velu, T. and Goldman, M.: Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol., 25: 2668, 1995.
14. Nomori, H.: Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer, 57: 100, 1986.
15. Nakano, T., Oka, K., Arai, T., Monta, S. and Tsuremoto, H.: Prognostic significance of Langerhans cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch. Pathol. Lab. Med., 113: 507, 1989.
16. Chaux, P., Favre, N., Martin, M. and Martin, F.: Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer, 72: 619, 1997.
17. Chaux, P., Moutet, M., Faivre, J., Martin, F. and Martin, M.: Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. Lab. Invest., 74: 975, 1996.
18. Banner, B. F., Burenhagen, J. A., Bahnson, R. R., Ernstoff, M. S. and Auerbach, H. E.: Immunophenotypic markers in the renal cell carcinoma. Mod. Pathol., 3: 129, 1990.
19. Whiteside, T. L. and Parmiani, G.: Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol. Immunother., 39: 15, 1994.
20. Thurnher, M., Radmayr, C., Ramoner, R., Ebner, S., Bock, G., Klocker, H., Romani, N. and Bartsch, G.: Human renal cell carcinoma tissue contains dendritic cells. Int. J. Cancer, 67: 1, 1996.
21. Troy, A. J, Summers, K. L, Davidson, P. J. T., Atkinson, C. H. and Derek, N. J.: Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin. Cancer Res., 4: 585, 1998.
22. Hsu, T.: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577, 1981.
23. + blood dendritic cells. Blood, 86: 3295, 1995.
24. Fearnley, D. B., McLellan, A. D., Mannering, S. I., Hock, B. D. and Hart, D. N. J.: Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen presenting cell function and immunotherapy. Blood, 89: 3708, 1997.
25. Schwaab, T., Wittke, F., Bottcher, J., Hoffmann, R., Dalmmann, I., Hussein, S., Ganser, A. and Atzpodien, J.: Dendritic Cells in Patients with Solid Tumor Brain Metastases. DGHO-Linz, 1997.
26. Beckman, E. M. and Brenner M. B.: MHC class I-like, class II-like and CD1 molecules: distinct roles in immunity. Immunol. Today, 16: 349, 1995.
27. Bauer, A., Huttinger, R., Staffler, G., Hansmann, C., Schmidt, W., Majdic, O., Knapp, W. and Stockinger, H.: Analysis of the requirement for b2-microglobulin for expression and formation of human CD1 antigens. Eur. J. Immunol., 27: 1366, 1997.
28. Beckman, E. M., Melian, A., Behar, S. M., Sieling, P. A., Chatterjee, D., Furlong, S. T., Matsumoto, R., Rosat, J. P., Modlin, R. L. and Portcelli, S. A.: CD1c restricted responses of mycobacteria-specific T cells. J. Immunol., 157: 2795, 1996.
29. Melian, A., Beckman, E. M., Porcelli, S. A. and Brenner, M. B.: Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr. Opin. Immunol., 8: 82, 1996.
30. Zheng, Z.-H., Castaño, A. R., Segelke, B. W., Stura, E. A., Peterson, P. A. and Wilson, I. A.: Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science, 277: 339, 1997.
31. Moody, D. B., Reinhold, B. B., Guy, M. R., Beckman, E. B., Frederique, D. E., Furlong, S. T., Ye, S., Reinhold, V. N., Sieling, P. A., Modlin, R. L., Besra, G. S. and Porcelli, S. A.: Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science, 278: 283, 1997.
32. Caux C, Massacre, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J.: Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180: 1263, 1994.
33. Mackey, F. M., Barth, R. J. Jr., and Noëlle, R. J.: The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol., 1999.
34. Hakomori, S.: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: an overview and perspectives. Cancer Res., 45: 2405, 1985.
35. x) antigens in renal cell carcinoma and normal kidney. J. Histochem. Cytochem., 39: 479, 1991.
36. Wright-Browne, V., McClain, K. L., Talpaz, M., Ordonez, N. and Estrov, Z.: Physiology and pathophysiology of dendritic cells. Hum. Pathol., 28: 563, 1997.
37. Sallusto, F. and Lanzavecchia, A.: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med., 179: 1109, 1994.
38. Kiertscher, S. M. and Roth, M. D.: Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J. Leukocyte Biol., 59: 208, 1996.
39. Szabolcs, O., Avigan, D., Gezelter, S., Ciocon, D. H., Moore, M. A., Steinman, R. M. and Young, J. W.: Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood, 87: 4520, 1996.